We are uniquely focused on collaborative research at the frontiers of life sciences, physical science, informatics, and engineering.
“Biotechnology brings together Rensselaer’s rich traditions in science and engineering,”
- Deepak Vashishth, CBIS DirectorAs a result of the center’s focus on both fundamental and applied research in biotechnology, new tools are being developed to delve into and better understand biology and ultimately to design new products and processes that will address key challenges and opportunities in health care, including drug safety, disease diagnosis and treatment, tissue engineering, and regenerative medicine.
Rensselaer has put its stamp on biotechnology research. In its first decade, CBIS scientists and engineers have created:
- Bioengineered therapeutics and antibacterial coatings for medical devices
- High-throughput diagnostic chips that enable rapid identification of drug candidates as well as toxins
- Bioengineered molecules, including a contamination-free form of the anticoagulant heparin
- Nanoscale therapeutics that inhibit anthrax toxins
- Stem cell bioengineering to aid in treatment of diseases including Alzheimer’s, osteoporosis, and osteoarthritis